Pieris Pharmaceuticals, Inc. has appointed Allan Reine as Senior Vice President and Chief Financial Officer, effective August 9, 2017. Dr. Reine is an accomplished healthcare investor and brings to Pieris a wealth of capital markets experience, a deep biotech background, and a strong scientific acumen. Prior to joining Pieris, from 2012 through August 2017, Dr. Reine was a portfolio manager at Lombard Odier Asset Management, where he ran a healthcare portfolio focused on biotechnology and pharmaceutical companies.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 USD | +2.07% | +6.26% | -28.85% |
05-15 | Pieris Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Pieris Pharmaceuticals Shares Fall After 1-for-80 Reverse Stock Split Announcement | MT |
1st Jan change | Capi. | |
---|---|---|
-28.85% | 13.4M | |
+13.15% | 118B | |
+12.77% | 106B | |
-3.97% | 24.28B | |
+1.19% | 21.96B | |
-9.30% | 18.16B | |
-42.12% | 16.37B | |
-17.23% | 15.56B | |
+4.78% | 13.63B | |
+32.27% | 12.27B |
- Stock Market
- Equities
- PIRS Stock
- News Pieris Pharmaceuticals, Inc.
- Pieris Pharmaceuticals, Inc. Appoints Allan Reine as Senior Vice President and Chief Financial Officer